Vaniqa

DRUG DESCRIPTION

VANIQA (eflornithine) is a cream containing 13.9% (139 mg/g) of anhydrous eflornithine hydrochloride as eflornithine hydrochloride monohydrate (150 mg/g).

Chemically, eflornithine hydrochloride is (±) -2- (difluoromethyl) ornithine monohydrochloride monohydrate, with the empirical formula C6H12F2N2O2•HCl•H2O, a molecular weight of 236.65 and the following structural formula:

VANIQA (eflornithine hydrochloride) structural formula illustration

Anhydrous eflornithine hydrochloride has an empirical formula C6H12F2N2O2• HCl and a molecular weight of 218.65.

Other ingredients include: ceteareth-20, cetearyl alcohol, dimethicone, glyceryl stearate, methylparaben, mineral oil, PEG-100 stearate, phenoxyethanol, propylparaben, stearyl alcohol and water.

What are the possible side effects of eflornithine topical (Vaniqa)?

Eflornithine topical may cause temporary redness, rash, burning, stinging, or tingling, especially if it is applied to broken or irritated skin. If irritation develops, reduce the application of eflornithine topical to once a day. If irritation continues, stop using eflornithine topical and contact your doctor.

Hair bumps (folliculitis) may also occur. If these continue, contact your doctor.

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is...

Read All Potential Side Effects and See Pictures of Vaniqa »

What are the precautions when taking eflornithine (Vaniqa)?

Before using this product, tell your doctor or pharmacist if you are allergic to eflornithine; or if you have any other allergies. This product may contain inactive ingredients (such as methylparaben), which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: cuts/infections/sores on face.

During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.

It is not known whether this drug passes into breast milk. Consult your doctor before...

Read All Potential Precautions of Vaniqa »


Vaniqa Consumer (continued)

SIDE EFFECTS: Burning, stinging, tingling, and redness of the skin may occur. If these effects persist or worsen, tell your doctor.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

Tell your doctor immediately if any of these unlikely but serious side effects occur: acne, "hair bumps" (folliculitis).

A very serious allergic reaction to this drug is rare. However, seek immediate medical attention if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

In the US -

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

PRECAUTIONS: Before using this product, tell your doctor or pharmacist if you are allergic to eflornithine; or if you have any other allergies. This product may contain inactive ingredients (such as methylparaben), which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: cuts/infections/sores on face.

During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.

It is not known whether this drug passes into breast milk. Consult your doctor before breast-feeding.


Vaniqa Patient Information Including Side Effects

Brand Names: Vaniqa

Generic Name: eflornithine topical (Pronunciation: ee FLOOR nih theen)

  • What is eflornithine topical (Vaniqa)?
  • What are the possible side effects of eflornithine topical (Vaniqa)?
  • What is the most important information I should know about eflornithine topical (Vaniqa)?
  • Who should not use eflornithine topical (Vaniqa)?
  • How should I use eflornithine topical (Vaniqa)?
  • What happens if I miss a dose (Vaniqa)?
  • What happens if I overdose (Vaniqa)?
  • What should I avoid while using eflornithine topical (Vaniqa)?
  • What other drugs will affect eflornithine topical (Vaniqa)?
  • Where can I get more information?

What is eflornithine topical (Vaniqa)?

Eflornithine interferes with a chemical in the hair follicles of the skin. This results in slower hair growth where eflornithine topical is applied.

Eflornithine topical is used to reduce unwanted facial hair in women. Eflornithine topical does not permanently remove hair or "cure" unwanted facial hair. Eflornithine topical will help you manage your condition and improve your appearance.

Eflornithine topical may also be used for purposes other than those listed in this medication guide.

What are the possible side effects of eflornithine topical (Vaniqa)?

Eflornithine topical may cause temporary redness, rash, burning, stinging, or tingling, especially if it is applied to broken or irritated skin. If irritation develops, reduce the application of eflornithine topical to once a day. If irritation continues, stop using eflornithine topical and contact your doctor.

Hair bumps (folliculitis) may also occur. If these continue, contact your doctor.

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.

What is the most important information I should know about eflornithine topical (Vaniqa)?

Eflornithine topical is for external use only.

Continue to use eflornithine topical even if you do not see immediate results. Reduction in facial hair occurs gradually. Improvement may be seen as early as 4 to 8 weeks of treatment, however it may take longer in some individuals. If no improvement is seen after 6 months of use, treatment with eflornithine topical should be discontinued. Hair growth may return to pretreatment levels approximately 8 weeks after discontinuation of treatment with eflornithine topical.

Related Drug Centers
  • Vaniqa


Related Drugs Index: